Sources | Names Used |
---|---|
CTRPv2 | sirolimus:bortezomib (250:1 mol/mol) |
PharmacoGx | sirolimus:bortezomib (250:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TCF4 | CTRPv2 | pan-cancer | AAC | 0.23 | 3e-10 |
mRNA | GGA2 | CTRPv2 | pan-cancer | AAC | 0.23 | 8e-10 |
mRNA | RHOH | CTRPv2 | pan-cancer | AAC | 0.25 | 1e-09 |
mRNA | CCDC117 | CTRPv2 | pan-cancer | AAC | 0.21 | 3e-09 |
mRNA | POU2AF1 | CTRPv2 | pan-cancer | AAC | 0.23 | 3e-09 |
mRNA | TOR3A | CTRPv2 | pan-cancer | AAC | 0.21 | 4e-09 |
mRNA | IGF2BP2 | CTRPv2 | pan-cancer | AAC | -0.22 | 4e-09 |
mRNA | FAM214A | CTRPv2 | pan-cancer | AAC | 0.21 | 7e-09 |
mRNA | PIK3CB | CTRPv2 | pan-cancer | AAC | -0.19 | 1e-08 |
mRNA | ZNF532 | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-08 |